Login/Sign Up

MRP ₹13486.5
(Inclusive of all Taxes)
₹2023.0 Cashback (15%)
Celvestrant 250 mg PFS Injection 5 ml is used to treat breast cancer in postmenopausal women. It contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth. In some cases, Celvestrant 250 mg PFS Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain.
Provide Delivery Location
About Celvestrant 250 mg PFS Injection 5 ml
Celvestrant 250 mg PFS Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Celvestrant 250 mg PFS Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Celvestrant 250 mg PFS Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Celvestrant 250 mg PFS Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Celvestrant 250 mg PFS Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Celvestrant 250 mg PFS Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Celvestrant 250 mg PFS Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Celvestrant 250 mg PFS Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Celvestrant 250 mg PFS Injection 5 ml.
Uses of Celvestrant 250 mg PFS Injection 5 ml
Celvestrant 250 mg PFS Injection 5 ml is used in the treatment of Breast cancer in postmenopausal women. The detailed uses of Celvestrant 250 mg PFS Injection 5 ml are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Celvestrant 250 mg PFS Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Celvestrant 250 mg PFS Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
How Celvestrant 250 mg PFS Injection 5 ml Works
Storage
What if I have taken an overdose of Celvestrant 250 mg PFS Injection 5 ml
Drug Warnings
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Celvestrant 250 mg PFS Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Celvestrant 250 mg PFS Injection 5 ml and for two years after the last dose is advised. Celvestrant 250 mg PFS Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Celvestrant 250 mg PFS Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Celvestrant 250 mg PFS Injection 5 ml.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXSamarth Life Sciences Pvt Ltd
₹8131
(₹1333.48/ 1ml)
RXGlenmark Pharmaceuticals Ltd
₹9239
(₹1663.02/ 1ml)
RX₹10889.46
(₹1785.87/ 1ml)
Alcohol
Caution
Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.
Pregnancy
Unsafe
Celvestrant 250 mg PFS Injection 5 ml is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Celvestrant 250 mg PFS Injection 5 ml and for two years after your last dose.
Breast Feeding
Unsafe
Celvestrant 250 mg PFS Injection 5 ml is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Celvestrant 250 mg PFS Injection 5 ml.
Driving
Safe if prescribed
Celvestrant 250 mg PFS Injection 5 ml usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Celvestrant 250 mg PFS Injection 5 ml.
Liver
Caution
Celvestrant 250 mg PFS Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Celvestrant 250 mg PFS Injection 5 ml.
Kidney
Caution
If you have kidney problems, inform your doctor before receiving Celvestrant 250 mg PFS Injection 5 ml.
Children
Unsafe
Celvestrant 250 mg PFS Injection 5 ml is not recommended for children and adolescents below 18 years of age.
Heart
Please inform your doctor if you have any pre-existing heart problems before using Celvestrant 250 mg PFS Injection 5 ml. Your doctor will prescribe Celvestrant 250 mg PFS Injection 5 ml if the benefits outweigh the risk.
Geriatrics
Safe if prescribed
Celvestrant 250 mg PFS Injection 5 ml is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Celvestrant 250 mg PFS Injection 5 ml is used to treat Breast cancer in postmenopausal women.
Celvestrant 250 mg PFS Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Celvestrant 250 mg PFS Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Celvestrant 250 mg PFS Injection 5 ml.
Celvestrant 250 mg PFS Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.
Celvestrant 250 mg PFS Injection 5 ml contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.
Celvestrant 250 mg PFS Injection 5 ml is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.
Celvestrant 250 mg PFS Injection 5 ml may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Celvestrant 250 mg PFS Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information